TRACON Gets EMA Orphan Drug Designation Status For Its TRC105 In Soft Tissue Sarcoma

By: via Benzinga
TRACON Pharmaceuticals (NASDAQ: TCON) revealed that the European Medicines Agency (EMA) has granted orphan drug designation status ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.